Triterpenoid compound for the treatment of diabetes
US5691386A · kind A · utility
16Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1996 |
| Grant date | Nov 25, 1997 |
| Priority date | — |
| Expiry date | Apr 16, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel hypoglycemically active triterpenoid compound isolated in purified, preferably substantially purified, form from Salacia spp., processes for obtaining the novel triterpenoid compound, compositions comprising the triterpenoid compound and methods for use a hypoglycemic agent, for example, in the treatment of diabetes, are described. In a preferred embodiment, the triterpenoid compound is obtained from Salacia prinoides. As an agent for the treatment of diabetes, the novel triterpenoid is useful for treating insulin-dependent (type I) and/or non-insulin-dependent (type II) diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.